Literature DB >> 172803

Lipoprotein receptors and genetic control of cholesterol metabolism in cultured human cells.

M S Brown, J L Goldstein.   

Abstract

Biochemical analysis of cultured fibroblasts obtained from human subjects with the autosomal dominant disorder familial hypercholesterolemia has led to the identification of a hitherto unrecognized cell-surface receptor for serum lipoproteins. This receptor plays a critical role in the physiologic regulation of cholesterol metabolism in human cells, and its absence leads to elevation of serum-cholesterol levels and severe atheroslerosis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172803     DOI: 10.1007/bf00625346

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  17 in total

Review 1.  Familial hypercholesterolemia: genetic, biochemical and pathophysiologic considerations.

Authors:  M S Brown; J L Goldstein
Journal:  Adv Intern Med       Date:  1975

2.  Homozygous familial hypercholesterolemia: specificity of the biochemical defect in cultured cells and feasibility of prenatal detection.

Authors:  J L Goldstein; M J Harrod; M S Brown
Journal:  Am J Hum Genet       Date:  1974-03       Impact factor: 11.025

3.  Expression of the familial hypercholesterolemia gene in heterozygotes: model for a dominant disorder in man.

Authors:  J L Goldstein; M S Brown
Journal:  Trans Assoc Am Physicians       Date:  1974

4.  Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol.

Authors:  M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

5.  Studies in the metabolism of cholesterol in subjects with normal plasma cholesterol levels and in patients with essential hypercholesterolaemia.

Authors:  B Lewis; N B Myant
Journal:  Clin Sci       Date:  1967-04       Impact factor: 6.124

6.  An evaluation of four methods for measuring cholesterol absorption by the intestine in man.

Authors:  E Quintão; S M Grundy; E H Ahrens
Journal:  J Lipid Res       Date:  1971-03       Impact factor: 5.922

7.  Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction.

Authors:  J L Goldstein; W R Hazzard; H G Schrott; E L Bierman; A G Motulsky
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

8.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

9.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

10.  Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1974-07-05       Impact factor: 47.728

View more
  5 in total

Review 1.  [Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)].

Authors:  W Gerok
Journal:  Klin Wochenschr       Date:  1979-06-15

Review 2.  Regulation of cholesterol metabolism in man and in other species.

Authors:  J M Dietschy
Journal:  Klin Wochenschr       Date:  1984-04-16

Review 3.  The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis.

Authors:  Angela Pirillo; Fabrizia Bonacina; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Curr Atheroscler Rep       Date:  2018-02-14       Impact factor: 5.113

4.  The effect of feeding human milk and adapted milk formulae on serum lipid and lipoprotein levels in young infants.

Authors:  V Wagner; H B von Stockhausen
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

5.  Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa.

Authors:  M F Baudet; C Dachet; J L Beaumont
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.